Asia‐inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trial

Abstract The investigational NEDD8‐activating enzyme inhibitor pevonedistat is being evaluated in combination with azacitidine versus single‐agent azacitidine in patients with higher‐risk myelodysplastic syndrome (higher‐risk MDS), higher‐risk chronic myelomonocytic leukemia (higher‐risk CMML), or l...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaofei Zhou (Author), Sharon Friedlander (Author), Erik Kupperman (Author), Farhad Sedarati (Author), Shingo Kuroda (Author), Zhaowei Hua (Author), Ying Yuan (Author), Yuka Yamamoto (Author), Douglas V. Faller (Author), Kazue Haikawa (Author), Katsuhiko Nakai (Author), Sharon Bowen (Author), Yi Dai (Author), Karthik Venkatakrishnan (Author)
Format: Book
Published: Wiley, 2021-05-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available